Super Shred

Super Shred is a high-potency, multi-compound research formulation engineered for studies exploring advanced lipid metabolism, mitochondrial energetics, and adrenergic receptor activation. Each milliliter delivers a precision-dosed combination of L-Carnitine, MIC blend, Adenosine Triphosphate (ATP), and Albuterol — four agents that act on distinct but complementary metabolic pathways, making Super Shred one of the most comprehensively targeted fat-metabolism compounds available for laboratory research models.

Formulation Breakdown

L-Carnitine — 400mg/ml

L-Carnitine is a quaternary ammonium compound that plays an essential role in the transport of long-chain fatty acids across the inner mitochondrial membrane, where they undergo beta-oxidation for energy production. Research models using L-Carnitine have consistently demonstrated improvements in fatty acid utilization, reduced accumulation of acylcarnitine intermediates, and enhanced exercise-related energy output. At 400mg/ml, this formulation provides a highly concentrated substrate for mitochondrial fatty acid flux studies.

MIC Blend — 100mg/ml (Methionine, Inositol, Choline)

The MIC (Methionine-Inositol-Choline) complex is a lipotropic blend widely studied for its role in hepatic fat metabolism and phospholipid biosynthesis. Methionine is a sulfur-containing essential amino acid that participates in methylation reactions and SAM (S-adenosylmethionine) synthesis, supporting hepatic detoxification and fat emulsification. Inositol modulates insulin signaling and plays a structural role in cell membrane phospholipids (PI pathway). Choline is a precursor to acetylcholine and phosphatidylcholine, critical for VLDL export from the liver and prevention of hepatic steatosis. Together, the MIC blend supports hepatic lipid mobilization and fat emulsification at the cellular level.

ATP — 50mg/ml (Adenosine Triphosphate)

Adenosine Triphosphate (ATP) is the primary cellular energy currency. Exogenous ATP has been investigated in research models for its role in purinergic receptor signaling (P2X/P2Y receptors), vasodilation, blood flow enhancement, and direct energy substrate replenishment in muscle tissue. Studies suggest that extracellular ATP may also stimulate lipolysis via receptor-mediated cAMP pathways. The inclusion of ATP in this formulation supports research into synergistic energy metabolism and cellular activation alongside adrenergic stimulation.

Albuterol — 2mg/ml

Albuterol (salbutamol) is a selective beta-2 adrenergic receptor agonist with well-documented thermogenic and lipolytic properties in research models. Activation of beta-2 receptors stimulates adenylyl cyclase, increasing intracellular cAMP, which in turn activates protein kinase A (PKA) and promotes hormone-sensitive lipase (HSL) activity — resulting in accelerated triglyceride breakdown and free fatty acid release. Research has also documented anabolic properties of beta-2 agonism via the mTOR pathway in skeletal muscle models. At 2mg/ml, this dose provides a targeted adrenergic stimulus suitable for in vitro and in vivo metabolic research protocols.

Research Applications

• Beta-adrenergic receptor activation and downstream cAMP/PKA signaling studies
• Mitochondrial fatty acid oxidation and carnitine shuttle dynamics
• Hepatic lipid metabolism and lipotropic pathway research
• Synergistic lipolysis modeling with multi-compound formulations
• ATP-mediated purinergic signaling and vascular response studies
• Energy substrate availability and exercise performance models

For research use only. Not intended for human consumption. This product has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease.